Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00844363 · ClinicalTrials.gov registry record · NA
Narrowband UVB Phototherapy in the Treatment of Psoriasis Vulgaris
A NA study, sponsored by Rockefeller University.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00844363 is a NA study that was terminated before completion, run by Rockefeller University. The registered enrollment target is 20 participants.
The verdict
NCT00844363, a NA study, was terminated before completion, sponsored by Rockefeller University.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Ultra-violet light B (UVB) therapy has been used by dermatologists to treat psoriasis for decades. Only a few studies have begun to dissect the mechanism of how NB-UVB therapy causes lesion resolution. Results from this study will aid in identifying other diseases that may be treated successfully with NB-UVB. If we can identify the mechanism of action of this therapy, this may give us additional new therapeutic targets for psoriasis and other diseases. Our overall hypothesis is that UVB induces changes that will indicate a mechanism of action of this therapy in psoriasis.
Interventions
- PROCEDURE NB-UVB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00844363
The ClinicalTrials.gov registry entry for NCT00844363 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NB-UVB is the first listed.
NCT00844363 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00844363 about?
NCT00844363 is a clinical study titled "Narrowband UVB Phototherapy in the Treatment of Psoriasis Vulgaris". Ultra-violet light B (UVB) therapy has been used by dermatologists to treat psoriasis for decades. Only a few studies have begun to dissect the mechanism of how NB-UVB therapy causes lesion resolution. Results from this study will aid in identifying other diseases that may be treated successfully wi...
What is the current status of trial NCT00844363?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2008-11. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00844363?
The interventions under investigation include: NB-UVB (PROCEDURE).
Who is sponsoring clinical trial NCT00844363?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.